With the increasing longevity and prevalence of cardiovascular disease, such as hypertension and chronic heart failure, there is an emerging epidemic of atrial fibrillation (AF) in almost all communities. According to the worldwide estimation in 2010, the prevalence of AF was 0.596% in men and 0.373% in women, and the estimated number of patients with AF worldwide was 33.5 million.1 A major complication of AF is embolic stroke. In a recent registry, AF accounted for a third of all ischemic strokes.2 Anticoagulation therapy with warfarin, a vitamin K antagonist,3 or non‐vitamin K–dependent oral anticoagulants4 has proved to be highly effective in the prevention of stroke in AF. The challenge is that AF is usually asymptomatic or only mildly symptomatic and therefore significantly underdiagnosed. A quarter to a third of stroke cases related to AF occur as the first manifestation of AF.5 Nonetheless, screening is possible and with current technology can be cost‐effective, if anticoagulation is successfully implemented. Screening for AF in persons older than 65 years may identify a prevalence of 1.4% with a single time point examination,6 3% with patient‐activated ECG recordings over 2 weeks,7 and 10.4% with an even longer‐term continuous ECG recordings technique.8 The consensus therefore is that AF should be screened in high‐risk individuals, such as those older than 65 years, by all possible means.9
Current consensus on AF screening recommends various modalities for opportunistic or systematic screening of AF.9 In addition to a variety of ECG recording techniques, pulse measurement by manual palpation at the radial artery or by an automated oscillometric blood pressure (BP) monitor at the brachial or radial arterial sites is also recommended for AF screening.9 Pulse palpation is apparently cheap and simple but less accurate and more difficult for the elderly people, who have high prevalence of AF.10 On the other hand, automated oscillometric BP monitors may provide accurate information on irregularity of the cardiac rhythm by measuring the width and amplitude of pulse waves during BP measurement.10 Hypertension is a major risk factor for AF. Home BP monitoring with an automated device is recommended in patients with treated hypertension. AF screening using a BP monitor is becoming promising.
Several models of BP monitors from various manufacturers were developed with an added function of irregular heartbeat detection (Table).11, 12, 13, 14, 15, 16, 17 Some of those devices were tested for accuracy in the detection of AF. Wiesel and colleagues11, 13, 15 have conducted a series of studies on AF detection during BP measurement. In a pioneering study, Wiesel and associates11 used an algorithm for the detection of AF during BP measurement on the basis of the last 10 pulses during cuff deflation. The irregularity index was defined as the standard deviation of the time intervals between successive heartbeats divided by the mean of the intervals. In a validation study against a standard 12‐lead ECG, an irregularity index of 0.06 or greater was used as the threshold for the diagnosis of AF.11 This algorithm was integrated in a home BP monitor (modified Omron 712C, Omron). In 450 outpatients including 54 with AF diagnosed by ECG, the diagnostic sensitivity was 100% and specificity was 84% during a single BP measurement.11 The false‐positive results were mainly seen in patients with frequent ectopic beats.11 The investigators then modified the algorithm by discarding pulse intervals of 25% shorter or 25% longer than the average and using the remaining time intervals for the calculation of the irregularity index. In a later study in 405 patients including 93 with AF diagnosed by ECG, the newer algorithm with a single BP measurement had a sensitivity and specificity of 95% and 86%, respectively.13 When three measurements were performed with at least two of the three indicating AF, the sensitivity and specificity rates were 97% and 89%, respectively.13
Table 1.
Studies on the diagnostic accuracy of automated blood pressure monitors for the detection of atrial fibrillation
| First author and year of publication | Study patients (No. of blood pressure measurements per patient) | Age, y | Prevalence of atrial fibrillation, % | Blood pressure–measuring devices | No. of blood pressure measurements | Accuracy against standard 12‐lead ECG | ||
|---|---|---|---|---|---|---|---|---|
| Used | Needed for diagnosis | Sensitivity, % | Specificity, % | |||||
| Wiesel 200411 | 450 Outpatientsa (2) | 69 | 12 | Modified Omron 712C | 1 (any) | 1 | 100 | 84 |
| 2 | 2 | 100 | 91 | |||||
| Stergiou 200912 | 72 Outpatients (3) | 71 | 37 | Microlife BPA100 Plus | 1 (any) | 1 | 96 | 83 |
| 2 (first) | 1 | 100 | 76 | |||||
| 3 | ≥2 | 100 | 89 | |||||
| Wiesel 200913 | 405 Outpatients (3) | 73 | 23 | Microlife BPM P3MQ1‐2D | 1 | 1 | 95 | 86 |
| 3 | ≥2 | 97 | 89 | |||||
| Marazzi 201214 | 503 Outpatients (1 for Omron and 3 for Microlife) | 67 | 20.1 | Omron M6 | 1 | 1 | 100 | 94 |
| Microlife BP A200 Plus | 3 | Not reported | 92 | 97 | ||||
| Wiesel 201415 | 183 Outpatients (1 for Omron and 3 for Microlife) | 74 | 16.4 | Omron M6 | 1 | 1 | 30 | 97 |
| Microlife BP A200 Plus | 1 (first) | 1 | 97 | 90 | ||||
| 3 | ≥2 | 100 | 92 | |||||
| Gandolfo 201516 | 207 Patients with strokea (3) | 78 | 18 | Microlife BPM P3MQ1‐2D | 3 | Not reported | 89 | 99 |
| Kearley 201517 | 999 Primary care patients (3?) | 80 | 7.9 | Microlife WatchBP | 3 (?) | Not reported | 95 | 90 |
The studies are listed according to the year of publication.
Including one11 and four patients16 with atrial flutter, which was detected as nonatrial fibrillation by the device and considered as false‐negative by the researchers.
Several other studies12, 14, 15, 16, 17 investigated BP monitors with an algorithm similar to the abovementioned modified algorithm and showed similar accuracy in the detection of AF, except one monitor that had a sensitivity of 30%.15 In general, these BP monitors had higher sensitivity and specificity in the detection of AF. Nonetheless, there is still some room for improvement, especially in reducing false‐positive results.
In this issue of the Journal, Kabutoya and colleagues18 reported a new algorithm for the detection of AF using a BP monitor. The authors believe that the new algorithm may further improve accuracy for the detection of AF during BP measurement. They defined a new index, called irregular pulse peak (IPP) 25, as the absolute difference between each interval of pulse peak and the average of the intervals of pulse peak ≥25% of the average of the intervals of pulse peak. If the number of IPP beats was ≥20% of the total number of pulses on two of the three BP measurements, AF could then be diagnosed. The sensitivity and specificity was 88% and 100%, respectively. If 20% and 15% was used as the threshold for the definition of IPP, the sensitivity was 94% and 100%, respectively, and the specificity was 100% for both thresholds.
This new algorithm is different from the previous algorithm in several aspects.11 First, the new algorithm used all of the pulse waves during cuff deflation instead of the last 10 pulse intervals only. Second, pulse intervals of 25% shorter or longer than the average were included for the definition of the irregularity index IPP25 in the new algorithm but discarded in the previous algorithm. Third, for the diagnosis, the new algorithm counted the number of IPPs, whereas the previous algorithm used a fixed threshold of ≥0.06 of the irregularity index.
The new algorithm was developed from a new angle to improve specificity in the detection of AF. However, cardiac arrhythmias other than AF were not included in this study.18 Both the current and previous algorithms were designed by assessing pulse rate irregularity. False‐positive results can be present in patients with irregular heartbeats other than AF, such as various forms of premature beats and sick sinus syndrome. In the absence of other ECG‐proven cardiac arrhythmias, the current study does not allow any inference on specificity in the presence of other cardiac arrhythmias. Indeed, the new algorithm may have false‐positive results in patients with frequent premature complexes, because, as previously demonstrated, intervals of 25% shorter or longer than the average could also be attributable to premature beats.11
Whether adding another dimension of the pulse waves, such as pulse amplitude, for instance, would help improve accuracy in the detection of AF remains under investigation. We previously investigated the accuracy of devices with an algorithm accounting for both the variation of the pulse duration and the variation of the pulse amplitude.19 The sensitivity and specificity in the detection of AF and frequent ectopic beats were higher than devices with an algorithm accounting for the variation of the pulse duration only.
Not only the algorithm but also the number of BP measurements may play a role. In a previous study, increasing the number of BP measurements from one to three and applying a majority rule (at least two of the three measurements showing AF) increased sensitivity from 95% to 97% and specificity from 86% to 89% for the detection of AF.13 A similar improvement was observed in another study in sensitivity from 93% to 100% and specificity from 83% to 89%.12
The AF detection function should probably become available in all BP monitors for home use. Preferably, the detection can be automatically transmitted to a clinical setting for decisions of further AF screening and eventually for the diagnosis and treatment of AF. With these technical capabilities, large‐scale outcome studies on AF screening should be conducted for the identification of AF and the prevention of stroke.
Chen Y, Lei L, Wang J‐G. Atrial fibrillation screening during automated blood pressure measurement—Comment on “Diagnostic accuracy of new algorithm to detect atrial fibrillation in a home blood pressure monitor.” J Clin Hypertens. 2017;19:1148–1151. 10.1111/jch.13081
REFERENCES
- 1. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837‐847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Friberg L, Rosenqvist M, Lindgren A, Terent A, Norrving B, Asplund K. High prevalence of atrial fibrillation among patients with ischemic stroke. Stroke. 2014;45:2599‐2605. [DOI] [PubMed] [Google Scholar]
- 3. Albers GW, Atwood JE, Hirsh J, Sherman DG, Hughes RA, Connolly SJ. Stroke prevention in nonvalvular atrial fibrillation. Ann Intern Med. 1991;115:727‐736. [DOI] [PubMed] [Google Scholar]
- 4. Sharma M, Cornelius VR, Patel JP, Davies JG, Molokhia M. Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism: systematic review and meta‐analysis. Circulation. 2015;132:194‐204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Freedman SB, Lowres N. Asymptomatic atrial fibrillation. The case for screening to prevent stroke. JAMA. 2015;314:1911‐1912. [DOI] [PubMed] [Google Scholar]
- 6. Lowres N, Neubeck L, Redfern J, Freedman SB. Screening to identify unknown atrial fibrillation. A systematic review. Thromb Haemost. 2013;110:213‐222. [DOI] [PubMed] [Google Scholar]
- 7. Svennberg E, Engdahl J, Al‐Khalili F, Friberg L, Frykman V, Rosenqvist M. Mass screening for untreated atrial fibrillation: the STROKESTOP Study. Circulation. 2015;131:2176‐2184. [DOI] [PubMed] [Google Scholar]
- 8. Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120‐129. [DOI] [PubMed] [Google Scholar]
- 9. Freedman B, Camm J, Calkins H, et al. Screening for atrial fibrillation: a report of the AF‐SCREEN International Collaboration. Circulation. 2017;135:1851‐1867. [DOI] [PubMed] [Google Scholar]
- 10. Taggar JS, Coleman T, Lewis S, Heneghan C, Jones M. Accuracy of methods for detecting an irregular pulse and suspected atrial fibrillation: a systematic review and meta‐analysis. Eur J Prev Cardiol. 2016;23:1330‐1338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Wiesel J, Wiesel D, Suri R, Messineo FC. The use of a modified sphygmomanometer to detect atrial fibrillation in outpatients. Pacing Clin Electrophysiol. 2004;27:639‐643. [DOI] [PubMed] [Google Scholar]
- 12. Stergiou GS, Karpettas N, Protogerou A, Nasothimiou EG, Kyriakidis M. Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation. J Hum Hypertens. 2009;23:654‐658. [DOI] [PubMed] [Google Scholar]
- 13. Wiesel J, Fitzig L, Herschman Y, Messineo FC. Detection of atrial fibrillation using a modified Microlife blood pressure monitor. Am J Hypertens. 2009;22:848‐852. [DOI] [PubMed] [Google Scholar]
- 14. Marazzi G, Iellamo F, Volterrani M, et al. Comparison of Microlife BP A200 Plus and Omron M6 blood pressure monitors to detect atrial fibrillation in hypertensive patients. Adv Ther. 2012;29:64‐70. [DOI] [PubMed] [Google Scholar]
- 15. Wiesel J, Arbesfeld B, Schechter D. Comparison of the Microlife blood pressure monitor with the Omron blood pressure monitor for detecting atrial fibrillation. Am J Cardiol. 2014;114:1046‐1048. [DOI] [PubMed] [Google Scholar]
- 16. Kearley K, Selwood M, Van den Bruel A, et al. Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single‐lead ECG and modified BP monitors. BMJ Open. 2014;4:e004565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Gandolfo C, Balestrino M, Bruno C, Finocchi C, Reale N. Validation of a simple method for atrial fibrillation screening in patients with stroke. Neurol Sci. 2015;36:1675‐1678. [DOI] [PubMed] [Google Scholar]
- 18. Kabutoya T, Imai Y, Hoshide S, Kario K. Diagnostic accuracy of new algorithm to detect atrial fibrillation in a home blood pressure monitor. J Clin Hypertens (Greenwich). 2017; 19:1143‐1147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Huang QF, Sheng CS, Zhang Y, Wang J, Li Y, Wang JG. Accuracy of automated oscillometric blood pressure monitors in the detection of cardiac arrhythmias. Blood Press Monit. 2009;14:91‐92. [DOI] [PubMed] [Google Scholar]
